Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 68 | 47 | 48 | 59 | 0 |
| Gross Profit | 68 | 47 | 48 | 59 | N/A |
| Operating Expenses | 30,347 | 27,212 | 25,790 | 30,535 | 27,349 |
| Operating Income | -30,279 | -27,165 | -25,742 | -30,476 | -27,349 |
| Other Income | 385 | 369 | 317 | 318 | 290 |
| Pre-tax Income | -29,894 | -26,796 | -25,425 | -30,158 | -27,059 |
| Income Tax | 23 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -29,917 | -26,935 | -25,425 | -30,158 | -27,059 |
| Net Income | $-29,917 | $-26,935 | $-25,425 | $-30,158 | $-27,059 |
| EPS Basic Total Ops | -10.64 | -9.60 | -10.34 | -12.59 | -11.24 |
| EPS Basic Continuous Ops | -10.71 | -9.55 | -10.35 | -12.57 | -11.31 |
| EPS Diluted Total Ops | -10.64 | -9.60 | -10.34 | -12.59 | -11.24 |
| EPS Diluted Continuous Ops | -10.71 | -9.55 | -10.35 | -12.57 | -11.31 |
| EBITDA(a) | $-29,829 | $-26,625 | $-25,319 | $-30,016 | $-26,856 |